Dementia Prevention in Latin America: A Focus on Modifiable Risk Factors

By Staff Writer

September 26, 2024

Introduction

Dementia prevalence in Latin America stands at 8.5%, the highest globally, and is projected to reach 19.3% by 2050. This sharp increase is driven by an ageing population, cardiovascular risk factors, low education levels, and social inequalities. Addressing modifiable risk factors for dementia is crucial in this context. Researchers aimed to calculate the Population Attributable Fractions (PAFs) for 12 modifiable risk factors using data from seven Latin American countries: Argentina, Brazil, Bolivia, Chile, Honduras, Mexico, and Peru. This information is vital for informing policies aimed at dementia prevention in the region.

Key Modifiable Risk Factors

This study revealed that 54% of dementia cases in Latin America could be avoided by targeting 12 modifiable risk factors. This percentage surpasses the global estimate of 40%. The major contributors in the meta-analysis were obesity in midlife, physical inactivity in later life, and depression.

Figure 1. Population attributable fractions for 12 modifiable risk factors for dementia in Argentina, Brazil, Bolivia, Chile, Honduras, Mexico, and Peru

Obesity

Obesity emerged as a significant risk factor, with PAFs consistently exceeding global estimates in all seven countries. The highest PAFs were observed in Mexico (9.4%) and Chile (8.8%). More than 50% of women in Latin America are overweight or obese, and two-thirds of women and over half of men are overweight or obese in Chile and Mexico. The rise in obesity is linked to increased consumption of ultra-processed foods and reduced intake of fruits, vegetables, and whole grains. Efforts to promote sustainable agricultural practices and policies supporting local food systems could help address these challenges.

Physical Inactivity

Physical inactivity PAFs were also high, particularly in Bolivia (10%) and Peru (9%). Lifestyle habits significantly influence these factors. Poor diet and physical inactivity are upstream risks for vascular diseases, leading to obesity and cardiovascular diseases that contribute to cognitive impairment. Obesity often co-occurs with insufficient physical activity, leading to higher rates of diabetes and hypertension. These non-communicable diseases are associated with neurodegeneration and systemic inflammation.

Mental Health and Depression

Depression is another critical factor, with PAFs ranging from 1.7% in Peru to 8.5% in Mexico, compared to the global estimate of 3.9%. Depression carries the highest relative risk for dementia and links with cardiovascular risk factors. It also ties to immune dysregulation and the accumulation of biomarkers related to Alzheimer’s disease. Moreover, it results in changes in brain structure. Variations in mental health awareness, stigma, and healthcare infrastructure contribute to the observed disparities in depression prevalence across the countries.

Education and Smoking

PAFs for less education were low in Argentina, Chile, Mexico, and Peru, not exceeding 2%. In contrast, Brazil and Honduras had PAFs consistent with global estimates (7%), while Bolivia had the highest PAF (11%). Despite progress in education over the past three decades, regional inequalities persist, particularly in low-income populations.

Smoking PAFs varied significantly, with the highest in Honduras (12%). Despite stringent laws prohibiting smoking in public areas, additional regulations might be needed to mitigate tobacco use. Implementing a 50% increase in cigarette prices through taxes could lead to a substantial reduction in deaths and disabilities attributed to smoking.

Policy Implications and Future Directions

This study highlights the importance of targeted interventions for dementia prevention in Latin America. While complete elimination of risk factors might not be feasible, identifying targets enables better management and prevention approaches. Population-level strategies, such as campaigns promoting healthy eating and regular physical activity, and increasing regulations or taxes on unhealthy foods and tobacco, would reduce exposure to such risk factors.

Ongoing randomised clinical trials like the Latin American Initiative for Lifestyle Intervention to Prevent Cognitive Decline will be crucial for providing evidence on risk reduction strategies at the individual level. Moreover, incorporating air pollutant concentration measures and better methods for assessing social isolation and traumatic brain injury will enhance future studies.

Findings clearly demonstrates the need for policies prioritising midlife obesity, late-life physical inactivity, and depression as initial targets for dementia prevention strategies. Addressing these factors could significantly reduce the dementia burden in Latin America.

Conclusion

In conclusion, 54% of dementia cases in Latin America could be prevented by mitigating 12 modifiable risk factors. This proportion varies from 45% in Peru to 62% in Chile, exceeding the 40% worldwide estimation. Midlife obesity, late-life physical inactivity, and depression are prominent contributors. These findings are vital for policy makers to develop effective dementia prevention strategies in Latin America and ensure healthy ageing for their populations.

Reference url

Recent Posts

lenacapavir HIV PrEP access
    

Global Health Partnerships Unite to Expand Access to Lenacapavir for HIV Prevention

💉 How can we ensure equitable access to HIV prevention methods like lenacapavir?

A recent initiative from the Global Fund, supported by key global health organizations, aims to provide affordable access to this new HIV pre-exposure prophylaxis medication.

With a goal to reach 2 million individuals over three years, this coordinated effort seeks to drastically cut HIV infections and align with our commitment to ending AIDS by 2030.

Explore the details of this impactful collaboration and how it could transform HIV prevention.

#SyenzaNews #globalhealth #HealthcareInnovation #MarketAccess

antimicrobial resistance africa
     

Africa’s Health Crisis: Antimicrobial Resistance and Mpox Outbreak

🌍 Are we prepared to tackle the hidden pandemic of antimicrobial resistance (AMR) in Africa?

With AMR rapidly becoming a dominant health crisis, it’s critical to understand its impact on our healthcare systems and most vulnerable populations.

The Africa CDC highlights the urgent need for substantial investment and coordinated responses to combat this escalating threat, alongside the ongoing Mpox outbreak.

Discover the pressing challenges and potential solutions in our latest article.

#SyenzaNews #GlobalHealth #HealthcareInnovation #AntimicrobialResistance #PublicHealth

BioSapien cancer drug delivery
    

BioSapien Innovative Cancer Drug Delivery Solutions

🌟 How is innovation in drug delivery shaping the future of cancer treatment? 🌟

Discover how UAE-based BioSapien is transforming the healthcare landscape with the MediChip™ platform, securing $5.5 million in pre-Series A funding to enhance cancer care.

This innovative solution promises to minimise side effects and improve treatment outcomes for patients, fully embracing the potential of biotechnology in the fight against cancer.

Read more about BioSapien’s journey and its impact on global health!

#SyenzaNews #biotechnology #oncology #innovation #HealthTech

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2024 Syenza™. All rights reserved.